Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis

Int J Mol Sci. 2021 Aug 12;22(16):8674. doi: 10.3390/ijms22168674.

Abstract

Pathological insults usually disturb the folding capacity of cellular proteins and lead to the accumulation of misfolded proteins in the endoplasmic reticulum (ER), which leads to so-called "ER stress". Increasing evidence indicates that ER stress acts as a trigger factor for the development and progression of many kidney diseases. The unfolded protein responses (UPRs), a set of molecular signals that resume proteostasis under ER stress, are thought to restore the adaptive process in chronic kidney disease (CKD) and renal fibrosis. Furthermore, the idea of targeting UPRs for CKD treatment has been well discussed in the past decade. This review summarizes the up-to-date literature regarding studies on the relationship between the UPRs, systemic fibrosis, and renal diseases. We also address the potential therapeutic possibilities of renal diseases based on the modulation of UPRs and ER proteostasis. Finally, we list some of the current UPR modulators and their therapeutic potentials.

Keywords: endoplasmic reticulum stress; fibrosis; kidney; proteostasis; unfolded protein responses.

Publication types

  • Review

MeSH terms

  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum Stress
  • Fibrosis
  • Humans
  • Molecular Targeted Therapy
  • Proteostasis / drug effects*
  • Renal Insufficiency, Chronic / drug therapy
  • Renal Insufficiency, Chronic / metabolism*
  • Renal Insufficiency, Chronic / pathology*
  • Signal Transduction / drug effects
  • Small Molecule Libraries / pharmacology*
  • Small Molecule Libraries / therapeutic use
  • Unfolded Protein Response / drug effects

Substances

  • Small Molecule Libraries